Affordable Access

Access to the full text

Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic

Authors
  • Gagneux-Brunon, Amandine1, 1
  • Schilte, Clémentine2
  • Garcin, Arnauld3
  • Jolly, Nathalie2
  • Vray, Muriel4
  • Schaeffer, Laura4
  • Duval, Xavier5
  • Hoen, Bruno6
  • Botelho-Nevers, Elisabeth1, 1
  • 1 University Hospital of Saint-Etienne, Saint-Etienne, 42055, France , Saint-Etienne (France)
  • 2 Center for Translational Science, Institut Pasteur, Paris, France , Paris (France)
  • 3 Unité de Recherche Clinique, Innovation et Pharmacologie, University Hospital of Saint-Etienne, Saint-Etienne, 42055, France , Saint-Etienne (France)
  • 4 Unité d’Epidémiologie des Maladies Emergentes, Institut Pasteur, INSERM, Paris, France , Paris (France)
  • 5 Inserm CIC-1425, AP-HP, Hôpital Universitaire Bichat; Inserm UMR-1137 IAME; Université Paris Diderot, UFR de Médecine-Bichat, Paris, France , Paris (France)
  • 6 Institut Pasteur, Paris, France , Paris (France)
Type
Published Article
Journal
Trials
Publisher
Springer (Biomed Central Ltd.)
Publication Date
May 30, 2021
Volume
22
Issue
1
Identifiers
DOI: 10.1186/s13063-021-05329-y
Source
Springer Nature
Keywords
License
Green
Report this publication

Statistics

Seen <100 times